HA

Hetalkumar Ashokkumar Shah

Active Director Additional Director DIN 05281085
DIN 05281085 First appointment Apr 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2019
Shareholding value •••• Premium profile

About Hetalkumar Ashokkumar Shah

Data last updated:

Hetalkumar Ashokkumar Shah is an Additional Director at Asmee Pharma Private Limited (since 2024), Director at Spa Pharma Private Limited (since 2020) and Director at Asknr Enterprises Private Limited (since 2025). The companies operate in Chemicals, Chemicals and Materials and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹2.76 Cr; the largest is Asmee Pharma Private Limited at ₹2.23 Cr (FY 2025). Earlier, Hetalkumar Ashokkumar Shah was a Director at Skinnonest Cosmeceuticals Private Limited (2022–2025) and Director at Ashok Gnxt Pharma Private Limited (2019–2022).

DIN 05281085
Primary Designation Additional Director
Industry Chemicals
First Appointment 02 Apr 2019
Oldest Company Age 16 yrs
Largest company Asmee Pharma Private Limited · ₹2.23 Cr (FY 2025)
Combined revenue ₹2.76 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asmee Pharma Private Limited U24290GJ2022PTC128955
Additional Director09 Oct 20242022₹2.23 Cr (FY 2025)Active
Spa Pharma Private Limited U24100GJ2010PTC059994
Director31 Dec 20202010₹53.1 Lakh (FY 2025)Active
Asknr Enterprises Private Limited U51909GJ2022PTC137327
Director07 Jan 20252022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Sep 20222022₹34.5 Lakh (FY 2025)Active
Ashok Gnxt Pharma Private Limited U51909GJ2019PTC107421
Director02 Apr 20192019₹34.06 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spa Pharma Private Limited
Asknr Enterprises Private Limited
Asmee Pharma Private Limited
Skinnonest Cosmeceuticals Private Limited
Premium access

Shareholding and investment profile for Hetalkumar Ashokkumar Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hetalkumar Ashokkumar Shah

Hetalkumar Ashokkumar Shah currently holds 3 directorships: Asmee Pharma Private Limited (Additional Director, since 09 Oct 2024, revenue ₹2.23 Cr (FY 2025)); Spa Pharma Private Limited (Director, since 31 Dec 2020, revenue ₹53.1 Lakh (FY 2025)); Asknr Enterprises Private Limited (Director, since 07 Jan 2025).

Hetalkumar Ashokkumar Shah was first appointed on 02 Apr 2019 as Director at Ashok Gnxt Pharma Private Limited. The most recent appointment on record is 07 Jan 2025 at Asknr Enterprises Private Limited.

The 2 current companies of Hetalkumar Ashokkumar Shah that report revenue have a combined latest revenue of ₹2.76 Cr: Asmee Pharma Private Limited ₹2.23 Cr (FY 2025); Spa Pharma Private Limited ₹53.1 Lakh (FY 2025).

Hetalkumar Ashokkumar Shah held 2 earlier board appointments: Skinnonest Cosmeceuticals Private Limited (Director, 08 Sep 2022 to 01 Jan 2025); Ashok Gnxt Pharma Private Limited (Director, 02 Apr 2019 to 30 Mar 2022).

The current boards of Hetalkumar Ashokkumar Shah's companies include Desai Shaunak Ashokbhai (Asmee Pharma Private Limited), Bhushan Pramodbhai Doshi (Spa Pharma Private Limited), Shilpankumar Jashbhai Patel (Spa Pharma Private Limited), Vikas Manekchand Soni (Spa Pharma Private Limited), Krinal Hetalkumar Shah (Asknr Enterprises Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available